EV/EBITDA
-5.03
-0.03-0.60%
Wed, 12 Mar 2025 20:29:45 GMT
Summary
- As of March 13, 2025, KPTI EV/EBITDA is -5.03, with a fall of -0.03 (-0.60%) during the most recent trading day.
- Over the past year, KPTI EV/EBITDA has dropped by -2.57 (-104.47%).
- KPTI EV/EBITDA is now -349.11% below its all-time high of -1.12.
Performance
KPTI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KPTI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.6% | +0.6% | +1.8% |
| 1 m1 month | +5.8% | -5.8% | -16.0% |
| 3 m3 months | -28.6% | -8.8% | -32.0% |
| 6 m6 months | -54.3% | -4.2% | -33.1% |
| ytdytd | +10.7% | -10.7% | -27.2% |
| 1 y1 year | -104.5% | -33.4% | -66.1% |
| 5 y5 years | +31.5% | -85.5% | -97.3% |
KPTI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -5.9% | -5.56 | +9.5% | |
| 3 m | 3-month | -3.61 | -39.3% | -6.13 | +17.9% |
| 6 m | 6-month | -3.18 | -58.2% | -6.13 | +17.9% |
| 1 y | 1-year | -2.09 | -140.7% | -6.13 | +17.9% |
| 3 y | 3-year | -1.76 | -185.8% | -10.62 | +52.6% |
| 5 y | 5-year | -1.76 | -185.8% | -11.13 | +54.8% |
| alltime | all time | -1.12 | -349.1% | -33.48 | +85.0% |
Karyopharm Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -5.03(-10.7%) |
| 2024 | -5.63(+197.9%) |
| 2023 | -1.89(-38.6%) |
| 2022 | -3.08(-37.4%) |
| 2021 | -4.92(-30.6%) |
| 2020 | -7.09(+3.8%) |
| Date | Value |
|---|---|
| 2019 | -6.83(+115.5%) |
| 2018 | -3.17(0.0%) |
| 2017 | -3.17(+0.3%) |
| 2016 | -3.16(-10.2%) |
| 2015 | -3.52(-75.3%) |
| 2014 | -14.23(-7.9%) |
| 2013 | -15.45 |
FAQ
- What is Karyopharm Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Karyopharm Therapeutics?
- What is KPTI EV/EBITDA year-to-date change?
- What is Karyopharm Therapeutics EV/EBITDA year-on-year change?
What is Karyopharm Therapeutics EV/EBITDA?
The current EV/EBITDA of KPTI is -5.03
What is the all time high EV/EBITDA for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high EV/EBITDA is -1.12
What is KPTI EV/EBITDA year-to-date change?
Karyopharm Therapeutics EV/EBITDA has changed by +0.60 (+10.66%) since the beginning of the year
What is Karyopharm Therapeutics EV/EBITDA year-on-year change?
Over the past year, KPTI EV/EBITDA has changed by -2.57 (-104.47%)